PRADEEP C JOLLY
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ATLANTA, GA NPI 1023096823
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GA E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$11,550.25
- Category: General Payments
- Program years: PY2018–2024
- Record count: 100
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,828.85 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,800.00 | 1 |
| Food and Beverage | $1,015.81 | 45 |
| Education | $13.04 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,800.00 | 1 |
| PFIZER INC. | $199.16 | 11 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $154.98 | 6 |
| Acerta Pharma LLC | $91.32 | 4 |
| Celgene Corporation | $74.71 | 3 |
| Lilly USA, LLC | $61.27 | 3 |
| GlaxoSmithKline, LLC. | $50.34 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.39 | 1 |
| Tempus AI, Inc | $30.49 | 1 |
| Astellas Pharma US Inc | $29.72 | 1 |
| Daiichi Sankyo Inc. | $29.69 | 1 |
| ABBVIE INC. | $27.90 | 1 |
| ARRAY BIOPHARMA INC | $27.15 | 2 |
| Janssen Biotech, Inc. | $24.95 | 1 |
| EISAI INC. | $24.61 | 1 |
| Merck Sharp & Dohme Corporation | $24.47 | 1 |
| BeiGene USA, Inc. | $24.24 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $23.38 | 1 |
| Mirati Therapeutics, Inc. | $22.44 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.47 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.59 | 1 |
| Immunocore Limited | $17.56 | 1 |
| Genentech USA, Inc. | $17.02 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.